Colgate-Palmolive Exceeds Expectations, Analysts Adjust Price Targets
Barclays raised its price target for Colgate-Palmolive (CL) to $80 from $79 and maintained an Equal Weight rating. Goldman Sachs increased its price goal to $100 from $98 while keeping a Buy rating due to the company's strong Q1 results, including higher-than-expected revenue, earnings, organic sales growth, and gross margins.
Topics: Colgate-Palmolive dividend stocks price targets Q1 results